Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. S. Borzenko"'
Autor:
E. S. Borzenko, I. V. Reshetov, A. S. Fatyanova, K. V. Ogdanskaya, M. M. Gafarov, Yu. S. Romanko
Publikováno v:
Biomedical Photonics, Vol 8, Iss 3, Pp 43-45 (2019)
The authors describe a clinical observation with full clinical effect after multi-course photodynamic therapy of a patient with central lung cancer and cystic fibrosis using Photoditazine. Photoditazine was administered intravenously at a dose of 0.8
Externí odkaz:
https://doaj.org/article/8de7600673fc4a3b977bf1b115e5bd19
Autor:
A. A. Mamedova, N. E. Mochkin, V. O. Sarzhevskiy, E. A. Demina, V. S. Bogatyrev, A. A. Spornik, A. A. Samoylova, A. A. Rukavitsin, E. G. Smirnova, A. E. Bannikova, V. Ya. Melnichenko, N. B. Mikhaylova, E. S. Borzenkova, L. V. Stelmakh, Yu. R. Zalyalov, A. A. Semenova, G. S. Tumyan, M. A. Danilova, O. A. Konova, N. A. Falaleeva, A. Yu. Terekhova, M. A. Vernyuk, A. M. Chervontseva, L. S. Khayrullina, A. A. Maslov, I. B. Lysenko, Yu. A. Alekseeva, E. S. Pavlyuchenko, A. A. Mirsaitov, A. A. Zverkova, I. V. Ishmatova, S. A. Volchenkov, M. S. Motalkina, I. S. Zyuzgin
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 40-47 (2022)
Aim. To study the efficacy and safety of combined immunochemotherapy according to the DHAp protocol + nivolumab in patients with refractory/relapsed classical Hodgkin's lymphoma before autologous hematopoietic stem cell transplantation.Materials and
Externí odkaz:
https://doaj.org/article/61dd8e7c89fc477eb1ba03f4c408b04b
Autor:
K. V. Lepik, N. V. Mikhailova, E. V. Kondakova, L. A. Tsvetkova, Yu. R. Zalyalov, E. S. Borzenkova, I. S. Moiseev, V. V. Baykov, B. A. Afanasyev
Publikováno v:
Онкогематология, Vol 13, Iss 4, Pp 17-26 (2019)
Background . Using modern first-line chemotherapy more than 80 % of patients with classical Hodgkin’s lymphoma can be cured, however, in 15–20 % of cases there is a relapsed/refractory disease. The use of nivolumab in international clinical pract
Externí odkaz:
https://doaj.org/article/e56b56508ac94cdab15e966db111c694